NTU Developmental Biology and Regenerative Medicine

國立臺灣大學發育生物學與再生醫學研究中心

Risk Factor Analysis for the Immunogenicity of Adalimumab Associated with Decreased Clinical Response in Chinese Patients with Psoriasis

  • 2015, Journal and Article​
Read More